Angel News

Back to Homepage

20th July 2020

Neurovalens raises more than £5 million to advance approvals of neurostimulation technology

Neurovalens, a global healthtech company headquartered in Belfast and San Diego, has raised £5.1 million in funding, led by IQ Capital. Wharton Asset Management Company, The Angel CoFund (ACF), Techstart Ventures, Clarendon Fund Managers, and the Government’s Future Fund also contributed to the funding round, which will be used to expand on the success of Neurovalens’ initial clinical trials and develop the technology’s application for other conditions.

...

Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:

Name:

Email:

Comment:

Enter the characters in the image shown:



Back to Homepage